Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Cash from Operations (2009 - 2026)

Evotec SE's (EVO) quarterly Cash from Operations came in at -$4.6 million in Q1 2026, up 86.3% year-over-year from -$2.5 million in Q1 2025, and up 25.01% quarter-over-quarter from -$6.1 million in Q4 2025.

Analysis

Evotec SE (EVO) Cash from Operations (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Cash from Operations across 9 years of filings, most recently posting -$4.6 million for Q1 2026.

  • In Q1 2026, Cash from Operations rose 86.3% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$59.6 million (down 255.5% YoY), while the FY2025 annual figure was -$10.4 million, down 152.59% from the prior year.
  • Cash from Operations came in at -$4.6 million for Q1 2026 at Evotec SE, up from -$6.1 million in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of $188.9 million in Q2 2022 to a low of -$79.0 million in Q3 2025.
  • Average Cash from Operations over 5 years is $10.4 million, with a median of -$4.3 million recorded in 2022.
  • Year-over-year, Cash from Operations jumped 2407103.0% in 2022 and sank 7889.36% in 2024.
  • Over 5 years, Cash from Operations stood at -$31.4 million in 2022, then surged by 168.24% to $21.5 million in 2023, then surged by 269.6% to $79.3 million in 2024, then plunged by 107.71% to -$6.1 million in 2025, then grew by 25.01% to -$4.6 million in 2026.
  • Per Business Quant data, the three most recent Cash from Operations figures were -$4.6 million in Q1 2026, -$6.1 million in Q4 2025, and -$79.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 162.01 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 281.27 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 179.73 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 28.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -44.27 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -492,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.90 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -3.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.58 Mn
Dec 31, 2025 -6.11 Mn
Sep 30, 2025 -78.98 Mn
Jun 30, 2025 30.06 Mn
Mar 31, 2025 -33.46 Mn
Dec 31, 2024 79.31 Mn
Sep 30, 2024 46.78 Mn
Jun 30, 2024 -54.30 Mn
Mar 31, 2024 -52.34 Mn
Dec 31, 2023 21.46 Mn
Jun 30, 2023 -6.75 Mn
Mar 31, 2023 671,911.98
Dec 31, 2022 -31.45 Mn
Sep 30, 2022 -4.01 Mn
Jun 30, 2022 188.86 Mn
Mar 31, 2022 71.40 Mn
Dec 31, 2021 74.01 Mn
Sep 30, 2021 24.53 Mn
Jun 30, 2021 49.50 Mn
Mar 31, 2021 2,966.13